Levatol Related Published Studies
Well-designed clinical trials related to Levatol (Penbutolol)
[The noninvasive assessment of the effects of penbutolol on liver hemodynamics in cirrhotic patients using angioscintigraphy. A randomized controlled double-blind study] [1990.11]
The influence of penbutolol and placebo on blood sugar levels and insulin consumption in the glucose-controlled insulin infusion system ("artificial endocrine pancreas"). [1990.10.03]
Angioscintigraphic assessment of hemodynamic effects of penbutolol in cirrhotics with portal hypertension. A double-blind, randomized, controlled study. [1990.08]
Penbutolol in the treatment of mild to moderate essential hypertension in black South Africans. [1990.06]
Effects of penbutolol on plasma atrial natriuretic peptide and antidiuretic hormone levels before and after exercise: a double-blind comparison against placebo. [1989]
[Treatment of essential mild-to-moderate arterial hypertension with once-daily penbutolol. Controlled clinical study vs atenolol] [1988.11]
Beta-blockers in hypertensive non-insulin-dependent diabetics: comparison between penbutolol and propranolol on metabolic control and response to insulin-induced hypoglycemia. [1988.04]
Well-designed clinical trials possibly related to Levatol (Penbutolol)
[Time-related effect of betapressin+ in patients with essential hypertension stage II] [1996]
[The effect of beta blockers on the QT interval: the possible role of mechanisms other than beta block] [1989.12]
Other research related to Levatol (Penbutolol)
In vivo microdialysis evidence for central serotonin1A and serotonin1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol. [1993.05]
Ventricular arrhythmias during exercise testing and daily activities in patients with stable angina pectoris before and during Aldisem and penbutolol treatment. [1993]
[Acute pulmonary edema and a state of shock in a female patient with a penbutolol-treated pheochromocytoma] [1992.11]
[Validity of the use of penbutolol in essential arterial hypertension] [1990.06]
Penbutolol and carteolol: two new beta-adrenergic blockers with partial agonism. [1990.05]
Penbutolol: a new beta-adrenergic blocking agent. [1990.04]
Usefulness of penbutolol for systemic hypertension. Penbutolol Research Group. [1989.06.01]
Effect of penbutolol on circadian blood pressure, and renin, aldosterone and cortisol levels in patients with essential hypertension. [1988]
Penbutolol: pharmacokinetics, effect on exercise tachycardia, and in vitro inhibition of radioligand binding. [1988]
[Penbutolol and arterial hypertension] [1987.09.30]
Kinetics of piretanide tablets, penbutolol tablets and the fixed combination of both drugs in healthy male subjects after a single oral dose. [1987]
Other possibly related research studies
Newer antihypertensive agents. [1991.04]
[Pharmacology of beta blockers and their significance for therapy of hypertension] [2002.08]
[beta-Adrenergic receptor blockers--a group of chiral drugs: different effects of each enantiomer] [2002.05]
beta-blocker binding to human 5-HT(1A) receptors in vivo and in vitro: implications for antidepressant therapy. [2000.09]
Serotonin receptor subtypes involved in the spinal antinociceptive effect of 5-HT in rats. [2000.05]
Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors. [1994.11.03]
Effects of acebutolol on the serum lipid profile. [1988]
[Effect of antianginal drugs on the exertion electrocardiogram] [1976.05]
|
